AnesthesiologyVideos + PDFs2024
Harvard 38th Annual Evaluating and Treating Pain 2024 — five days from headache to cancer pain, opioids to mind–body care
Harvard 38th Annual Evaluating and Treating Pain 2024 records the 17–21 June 2024 edition of the long-running Harvard pain review, led by Carol Warfield. Its 44 sessions draw on anaesthesia, neurology, psychiatry, rehabilitation, orthopaedics and neurosurgery, moving from examination skills to headache and neuropathy, cancer and spinal pain, analgesic pharmacology and opioid safety, and finally psychological and mind–body treatment. Three evening workshops — yoga and breathing, botulinum toxin injection and difficult conversations — are included.
- 44sessions
- 5days
- 3evening workshops
- 2024edition
What you’ll be able to do
- Carry out focused musculoskeletal, neurological and psychosocial assessments of the patient in pain
- Diagnose and treat headache, trigeminal neuralgia and neuropathic pain, including CRPS and post-herpetic neuralgia
- Manage cancer and end-of-life pain with medical, interventional and palliative approaches
- Decide when spinal pain calls for injections or surgery
- Prescribe opioids, NSAIDs, ketamine and cannabis rationally and handle addiction risk
- Offer CBT, meditation, yoga and other non-drug options with confidence
Inside the course
Assessment and whole-person pain
Pain pathophysiology, examination techniques, disability evaluation, fibromyalgia and myofascial pain, and a frank look at supplements, acupuncture and tai chi.
Head, face and nerves
A neurology-heavy day on headache, craniofacial nerve blocks and toxin, trigeminal neuralgia, cervicogenic headache, peripheral neuropathy, shingles-related pain and complex regional pain syndrome.
Evaluating and Treating Pain in cancer, joints and spine
Cancer pain options and interventions, palliative care, shoulder, knee and foot disorders, then low back and neck pain from diagnosis through injections to surgery.
Drugs, dependence and the mind
Ketamine, medical marijuana, NSAIDs, new analgesics, opioid prescribing and medico-legal issues, addiction and toxicology screening, the difficult patient, CBT and the relaxation response — plus a closing talk on PRP and stem cells.
Built for
- Anaesthesiologists and pain physiciansA broad yearly update spanning the specialty.
- Primary care physiciansPractical assessment and prescribing for the chronic pain patients they carry.
- Psychologists and rehabilitation cliniciansBehavioural and mind–body sessions alongside the medical content.
Faculty & syllabus
Before you buy
Which Harvard pain course edition should I choose?
This is the 2024 (38th) meeting. The 2026 (40th) edition is newer and sold separately, and a 2022 recording is also available if you want an earlier line-up.
Why do some 2024 pain sessions show no speaker?
The published agenda left five talks without a named presenter, so they appear by title only in the list below.
Are the expert Q&A panels counted in the 44?
No. Each block ended with a questions-to-the-experts segment; those panels are not counted as separate sessions here.
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Videos + PDFs |
|---|---|
| Dates | 17–21 June 2024 |
| Programme | 44 sessions incl. 3 workshops |
| Course director | Carol Warfield, MD |
| Publisher | Harvard Medical School |
| Department | Anesthesiology |
| Delivery | Instant download · lifetime re-download |


